Related Experiment Videos
Studies on type II progesterone receptor in MCF-7 cells
D E Saunders1, C Christensen, S C Brooks
1Department of Biochemistry, Wayne State University School of Medicine, Detroit, MI 48201.
Steroids
|September 1, 1988
Summary
Scientists discovered a new progesterone receptor (RpII) in breast cancer cells, distinct from the classical type. This novel receptor shows different binding affinities and cellular localization, offering new insights into hormone action in cancer.
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- Progesterone receptors are critical in regulating cellular functions, particularly in hormone-responsive tissues like the breast.
- Understanding the different types and behaviors of progesterone receptors is essential for developing targeted cancer therapies.
Purpose of the Study:
- To identify and characterize a potential Type II progesterone receptor (RpII) in MCF-7 human breast cancer cells.
- To compare the binding affinity and cellular localization of RpII with the classical progesterone receptor (Rp).
Main Methods:
- Utilized radioligand binding assays with tritiated progesterone ([3H]Pg) to quantify receptor levels.
- Employed Scatchard analysis to determine binding affinities (Kd) and receptor characteristics.
- Performed cytosolic, nuclear, and whole-cell assays to assess receptor localization.
- Investigated receptor recompartmentalization and expression levels following hormonal treatments (estradiol and progesterone).
Main Results:
- Demonstrated the existence of RpII in MCF-7 cells, exhibiting lower progesterone affinity (Kd ≥ 13 nM) compared to classical Rp (Kd ≤ 3 nM).
- RpII was detected in cytosolic, nuclear, and whole-cell fractions.
- Unlike classical Rp, RpII did not readily recompartmentalize to the nucleus upon progesterone stimulation.
- RpII expression levels significantly increased (over two-fold) after prolonged exposure to both estradiol (E2) and progesterone (Pg).
Conclusions:
- MCF-7 cells possess a distinct Type II progesterone receptor (RpII) with unique biochemical properties.
- RpII's differential binding affinity and localization suggest a potentially separate functional role in breast cancer cells.
- The upregulation of RpII by E2 and Pg indicates its involvement in hormone-driven breast cancer progression.